Daily Bulletin

The Times Real Estate

.

  • Written by Pitch Engine
Global Oncology/Cancer Drugs Market (Therapeutic Modalities, Cancer Types and Geography) - Size, Share, Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020 is a new market research publication announced by Reportstack. Biological drugs based on monoclonal antibodies (mAbs) have emerged as a preferred option for treating various cancer types, especially for blood cancer (leukemia). Rising incidence of various cancer conditions, growing popularity of advance therapies (biological and targeted drug therapies), patents expiration of leading drugs along with commercialization of biosimilars are the few factors driving the growth of global oncology drugs market. However, high cost involved in new drug development coupled with threat of failure and adverse effects associated with cancer drugs therapies would restrain the growth of the market. Commercialization of advanced therapeutics such as targeted and immunotherapies would reduce the negative influence of restraints and fuel the market growth.

The global oncology drugs market is expected to reach at $111.9 billion by 2020. Patent expiration of key cancer drugs such as Herceptin, Erbitux, Rituxan and Avastin, is expected to boost the growth of cancer biosimilars market by 2020. Going further, the biological therapies are expected to dominate the market by 2020, due to their high efficacy, target specific action and less toxicity. Blood cancer drugs market was the largest revenue generating segment in 2013 owing to the high cost of drugs (immunotherapies) used for the treatment of blood cancer.

Geographically, North America, dominates the market followed by Europe. North America accounted for about ~38% share in the overall oncology drugs market in 2013 owing to the heavy investments by multinational companies in research and development of cancer drugs, particularly immune therapeutics, favorable reimbursement policies, and high adoption rate of immunotherapies. On the other hand, Asia-Pacific market would grow at the promising CAGR of 8.7% during the forecast period. Such high growth rate is majorly due to increasing awareness towards advanced therapies namely immunotherapies and increase in per capita healthcare spending.

Key companies profiled in the report are Roche diagnostics, Novartis AG, Celgene Corporation, AstraZeneca, Johnson & Johnson, Merck & Co., Eli Lilly & Co. and GlaxoSmithKline. Companies operating in the cancer drugs market focus on several strategies such as collaboration, approval and acquisition.KEY BENEFITS

The report provides the quantitative analysis of the current market and estimations through 2013-2020 that assists in identifying the prevailing market opportunities to capitalize onThe report helps in understanding the strategies adopted by various companies for gaining market share in the cancer drugs marketThe report provides comprehensive analysis of factors that drive and restrict the growth of the cancer drugs marketMarket conditions of cancer drugs market across all geographic regions are comprehensively analyzedCompetitive intelligence (of leading manufacturers) helps in understanding the competitive scenario across the geographiesSWOT analysis of the key market players is provided to illustrate the business strategies adopted by the companiesMARKET SEGMENTATIONThe cancer drugs market is segmented by the therapeutic modalities, cancer types and geography.

MARKET BY THERAPEUTIC MODALITIESChemotherapyTargeted TherapyImmunotherapy (Biologic Therapy)Hormonal TherapyOthersMARKET BY CANCER TYPESBlood CancerBreast CancerGastrointestinal CancerProstate CancerRespiratory/Lung CancerSkin CancerOther CancersMARKET BY GEOGRAPHY

North AmericaUnited StatesCanadaMexicoEuropeGermanyFranceUnited KingdomOthersAsia-PacificIndiaChinaJapanAustraliaOthersLAMEAGCC (Gulf Corporation Council)Others

Companies Mentioned

Amgen Inc., Johnson and Johnson, Roche Diagnostics, GlaxoSmithKline PLC, Merck & Company, Novartis AG, Pfizer, Sanofi, Eli Lilly and Company, Celgene Corporation

Contact:

Debora White

debora@reportstack.com

Ph: +1-888-789-6604

Reportstack Market Research

Authors: Pitch Engine

Read more http://www.pitchengine.com/pitches/16c14321-4ea0-4cbc-86e8-13dc455583f8

Business News

Maintaining Garden Aesthetics Year-Round: Seasonal Gardening for Killara Businesses

Seasonal gardening gives Killara businesses the chance to have beautiful outside areas all year round. Landscaping strategies are changed during the different seasons to help plants grow well in cha...

Daily Bulletin - avatar Daily Bulletin

Site Survey: The Foundation of Successful Construction Projects

A site survey (or land survey) is an essential early step in establishing the requirements for the successful execution and planning of construction and land development. It is a large-scale process...

Daily Bulletin - avatar Daily Bulletin

Why Brite Storage Tanks Are a Game-Changer for Your Beverage Production

Whether you’re brewing a refreshing pale ale or perfecting your cider, every step shapes the final product. That’s where brite storage tanks truly shine. Crafting beverages Australians love takes mor...

Daily Bulletin - avatar Daily Bulletin

LayBy Deals